BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 1004644)

  • 1. Induction of platelet aggregation by the complement-derived peptides C3a and C5a.
    Grossklaus C; Damerau B; Lemgo E; Vogt W
    Naunyn Schmiedebergs Arch Pharmacol; 1976 Oct; 295(1):71-6. PubMed ID: 1004644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of C3a and C5a anaphylatoxins on guinea-pig isolated blood vessels.
    Marceau F; Hugli TE
    J Pharmacol Exp Ther; 1984 Sep; 230(3):749-54. PubMed ID: 6332191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary injury induced by C3a and C5a anaphylatoxins.
    Stimler NP; Hugli TE; Bloor CM
    Am J Pathol; 1980 Aug; 100(2):327-48. PubMed ID: 6967702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of human anaphylatoxins on guinea pig atria.
    Huey R; Bloor CM; Hugli TE
    Immunopharmacology; 1984 Dec; 8(3-4):147-54. PubMed ID: 6335143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotactic effects of the complement-derived peptides C3a, C3ai and C5a (classical anaphylatoxin) on rabbit and guinea-pig polymorphonuclear leukocytes.
    Damerau B; Grünefeld E; Vogt W
    Naunyn Schmiedebergs Arch Pharmacol; 1978 Nov; 305(2):181-4. PubMed ID: 732894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of histamine in the spasmogenic effect of the complement peptides C3a and C5a-desArg (classical anaphylatoxin).
    Sorgenfrei J; Damerau B; Vogt W
    Agents Actions; 1982 Apr; 12(1-2):118-21. PubMed ID: 6177210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative study on biological activities of various anaphylatoxins (C4a, C3a, C5a). Investigations on their ability to induce platelet secretion.
    Meuer S; Hugli TE; Andreatta RH; Hadding U; Bitter-Suermann D
    Inflammation; 1981 Dec; 5(4):263-73. PubMed ID: 6976935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proceedings: Effect of the complement-derived peptides C3a and C5a (anaphylatoxin) on platelets of different species, in vitro.
    Grossklaus C; Damerau B; Vogt W
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 287 Suppl():R59. PubMed ID: 1143463
    [No Abstract]   [Full Text] [Related]  

  • 9. Anaphylatoxin-induced neutrophil chemotaxis and aggregation. Limited aggregation and specific desensitization induced by human C3a and synthetic C3a octapeptides.
    Nagata S; Glovsky MM; Kunkel SL
    Int Arch Allergy Appl Immunol; 1987; 82(1):4-9. PubMed ID: 3492446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of the anaphylatoxins C3a and C5a on isolated mast cells from rat and man.
    Jürgensen H; Behrendt H; Damerau B; Schmutzler W
    Agents Actions; 1986 Apr; 18(1-2):153-4. PubMed ID: 2425572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C3a induced activation and stimulus specific reversible desensitization of guinea pig platelets.
    Zanker B; Rasokat H; Hadding U; Bitter-Suermann D
    Agents Actions Suppl; 1982; 11():147-57. PubMed ID: 6983827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of the N-terminal regions of hog C3a, C5a and C5a-desArg in their biological activities.
    Damerau B; Zimmermann B; Czorniak K; Wüstefeld H; Vogt W
    Mol Immunol; 1986 Apr; 23(4):433-40. PubMed ID: 3487713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Demonstration of a specific C3a receptor on guinea pig platelets.
    Fukuoka Y; Hugli TE
    J Immunol; 1988 May; 140(10):3496-501. PubMed ID: 3283237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthetic C3a analogs as specific inhibitors of C3a activity.
    Meuer S; Hadding U; Andreatta R; Bitter-Suermann D
    Immunopharmacology; 1981 Sep; 3(3):275-80. PubMed ID: 6975766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet-serotonin release by C3a and C5a: two independent pathways of activation.
    Meuer S; Ecker U; Hadding U; Bitter-Suermann D
    J Immunol; 1981 Apr; 126(4):1506-9. PubMed ID: 7204973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anaphylactic actions of platelet-activating factor.
    Stimler NP; Bloor CM; Hugli TE; Wykle RL; McCall CE; O'Flaherty JT
    Am J Pathol; 1981 Oct; 105(1):64-9. PubMed ID: 6975043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of the complement anaphylatoxins in inflammation and hypersensitivity reactions in the lung.
    Stimler-Gerard NP
    Surv Synth Pathol Res; 1985; 4(5-6):423-42. PubMed ID: 3879815
    [No Abstract]   [Full Text] [Related]  

  • 18. Low zone desensitization: a stimulus-specific control mechanism of cell response. Investigations on anaphylatoxin-induced platelet secretion.
    Meuer S; Zanker B; Hadding U; Bitter-Suermann D
    J Exp Med; 1982 Mar; 155(3):698-710. PubMed ID: 6977607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anaphylatoxin-induced release of histamine from in vitro perfused guinea pig kidney.
    Abdullah NA; Assem ES; Damerau B
    Agents Actions; 1988 Apr; 23(3-4):181-4. PubMed ID: 2455983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The active site of human C4a anaphylatoxin.
    Hugli TE; Kawahara MS; Unson CG; Molinar-Rode R; Erickson BW
    Mol Immunol; 1983 Jun; 20(6):637-45. PubMed ID: 6603573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.